Membrane Oxygenators Market Analysis Report By Type, By Application, By Age Group, By Region And Segment Forecasts From 2021 To 2028

Synopsis

The global membrane oxygenators market was prized by USD 118.8 million in 2020. It is estimated to witness 1.5% CAGR from 2021 to 2028.

Drivers

Membrane oxygenators are utilized in taking care of the patients, affected by persistent cardiopulmonary and respiratory sickness. They possess extensive functions and are utilized for the therapy of adults, neonates, and pediatric patients.

The rising commonness of cardiovascular and respiratory illness, increasing figure of extracorporeal membrane oxygenator centers, growing acceptance of these oxygenators like a linkage to lung transplantation are the number of most important factors, increasing the enlargement of the market for membrane oxygenators.

Technical progressions, seminars and training programs to boost knowledge, are the factors expected to additionally promote the expansion of the market. These oxygenators were vigorously used in acute Covid-19 situations, during the initial two waves of the pandemic. The functions of these oxygenators are speedily increasing.

The rising frequency of cardiopulmonary disorders is expected to impel the demand for membrane oxygenators, during the study phase. The major reasons of cardiopulmonary sicknesses comprise smoking, unhealthful eating habits, tobacco utilization and physical idleness. The growing figure of cardiovascular illnesses is likely to impel the requirement for these oxygenators in elderly, pediatric, and adult, patients.

Age Group Insight

The adult section held the major, 56.2% revenue share and led the membrane oxygenator market, in 2020. The most important sign that indicates the necessity for membrane oxygenation is Cardiogenic shock, in the situation of adult cardiac malfunction. A progression in membrane oxygenator equipment has improved its use in the adult therapy.

The neonate section is likely to demonstrate substantial CAGR, during the forecast period. A membrane oxygenator is usually utilized to administer neonates along with cardiac and respiratory malfunction.

The rising quantity of neonates is anticipated to increase the requirement for membrane oxygenators. On the other hand, as a result of the latest improvement of minimally invasive methods of treatment, used for the neonatal respiratory malfunction, the overall quantity of neonates taken care with membrane oxygenators is considerably reducing, in the due course. This is restricting the expansion of the section.

Type Insight

The hollow fiber membrane oxygenators sector held the biggest, 63.4% revenue share and led the market, in 2020. Hollow-fiber membrane oxygenators are made up of a greater quantity of fibers, having semi-porous walls plus innermost lumen by holes, which are adequately big to transfer water from end to end.

Hollow-fiber membrane oxygenators contain openings, which permit the release of gas, rapidly, de-airing the threads. Therefore, these kinds of oxygenators have been incorporated into a small number of ECLS track intended for the help, following cardiac arrest or shock, like a quick reaction arrangement. This is impelling the expansion of the sector.

The flat sheet membrane oxygenators sector is the succeeding major sector promise having assured development openings. These membrane oxygenators do not contain gaps in the membrane partition and rely on the permeability of plastic material. This permits the movement of gas by way of the membranes.

As contrast to hollow-fiber oxygenators that normally necessitate substitution in 6 to 12 hours, flat sheet membrane oxygenators comprise extended life duration, by means of consent for use equal to 14 days. This is likely to augment their acceptance, during the forecast period.

Application Insight

The respiratory division held the main; 51.8% revenue share and led the membrane oxygenators market, in 2020. Usually, membrane oxygenators are applied to take care of the patients affected by acute respiratory illness, for example respiratory failure. They are utilized in serious pneumonia, meconium aspiration syndrome, pulmonary hypertension, respiratory failure, and respiratory distress syndrome. This shows greater applicability. But, the likelihood of tricky situation likes creation of blood clot, infection, and bleeding, might affect, adversely, on the enlargement of the market.

The ECPR division is expected to develop by a profitable 1.9% CAGR, throughout the forecast period. Centrifugal pumps incorporated with hollow fiber oxygenators are utilized in ECPR. A variety of threats due to this kind of use are, several organ failures; in addition to or neurological damage, reperfusion damage that might initiate sepsis, intracranial hemorrhage, that might prove to be lethal. The additional hazards comprise functional cannula failures, vascular damage, that can source bleeding problems, hampering the development of the division.

Besides, stoppage in continuing stable blood stream, might produce suboptimal supports otherwise death. Approximately 350,000 people every year undergo cardiac arrest in the U.S., and beyond them. Nearly 1% to 2% of pediatric admittances necessitate cardiopulmonary resuscitation (CPR). Therefore; rising occurrences of cardiac arrest are expected to promote escalation of the division.

Regional Insight

In 2020, North America held the major, 40.4% revenue share and led the global membrane oxygenators market. The region is anticipated to carry on its supremacy, during the forecast period. The accessibility of strong primary, secondary, and tertiary care hospitals is behind the enlargement of the local market.

Besides, rising alertness about the membrane oxygenator machines, the existence of a strong compensation system, and encouraging financial support by the government are the factors, increasing its acceptance in the hospitals. Technical progressions in membrane oxygenators are, moreover, supporting the expansion of the market.

The market in Asia Pacific is expected to display the highest, 2.1% CAGR, during the forecast period. The rising occurrences of chronic sicknesses like cardiopulmonary illness because of the surplus use of tobacco, unhealthful eating practices, along with increasing alertness regarding membrane oxygenators, have caused a growth in its acceptance speed in the hospitals.

Furthermore, a variety of government schemes being taken on and the accomplishment speed of Extracorporeal Membrane Oxygenation (ECMO) arrangement in the course of cardiothoracic surgical treatment are likely to increase the expansion of the market. Low down per capita earnings along with a huge population of Asia Pacific initiated a greater demand for the reasonably priced alternatives used for the treatment. Global companies are scheduling to invest in emergent nations like China. This is, additionally, projected to increase the market during the forecast period.

Companies

The companies have adopted important policies to maintain their share in the market such as, modernization, product presentation, and tactical acquirement.

Some of the companies for membrane oxygenators market are:

    • Micro Port Scientific Corporation
    • Getinge AB
    • Medtronic
    • Nipro Medical Corporation
    • Terumo Medical Corporation
    • Fresenius SE & Co KGaA

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Million Insights has segmented the global membrane oxygenators market report based on type, application, age group, and region:

• Type Outlook (Revenue, USD Million, 2016 - 2028)
    • Hollow Fiber Membrane Oxygenators
    • Flat Sheet Membrane Oxygenators

• Application Outlook (Revenue, USD Million, 2016 - 2028)
    • Respiratory
        • Respiratory failure
        • Pulmonary embolism
        • Acute respiratory distress syndrome
        • Pneumonia
        • COVID-19
    • Cardiac
        • Acute myocardial infarction
        • Myocarditis
        • Post-transplant complications
        • Decompensated cardiomyopathy
        • Cardiogenic shock
    • ECPR

• Age group Outlook (Revenue, USD Million, 2016 - 2028)
    • Neonates
    • Pediatrics
    • Adults

• Regional Outlook (Revenue, USD Million, 2016 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • U.K
        • Germany
        • France
        • Italy
        • Spain
    • Asia Pacific
        • Japan
        • China
        • India
        • South Korea
        • Australia
        • Thailand
    • Latin America
        • Brazil
        • Mexico
        • Argentina
        • Colombia
    • Middle East & Africa
        • South Africa
        • Saudi Arabia
        • UAE